Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer von Van Poppel, Hendrik, Abrahamsson, Per‐Anders

Volltext

Androgen deprivation therapy and side effects: are GnRH antagonists safer? von Freedland, Stephen J, Abrahamsson, Per-Anders

Volltext

The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study von Dizeyi, Nishtman, Mattisson, Ingrid Yao, Ramnemark, Lena, Grabe, Magnus, Abrahamsson, Per‐Anders

Volltext

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer von Carducci, Michael A., Saad, Fred, Abrahamsson, Per‐Anders, Dearnaley, David P., Schulman, Claude C., North, Scott A., Sleep, Darryl J., Isaacson, Jeffrey D., Nelson, Joel B.

Volltext

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots von Abrahamsson, Per-Anders

Volltext

Editorial for the Abstracts of the 20th Meeting of the Association of Academic European Urologists [European Urology Open Science 2023;48(Suppl 1):S1–48] von Heesakkers, John, Debruyne, Frans, Abrahamsson, Per-Anders

Volltext

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature von Abrahamsson, Per-Anders

Volltext

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up von Johnson, Heather, Guo, Jinan, Zhang, Xuhui, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan H B, Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Kenner, Lukas, Feng, Xiaoyan, Zou, Chang, Xiao, Kefeng, Persson, Jenny L, Chen, Lingwu

Volltext

Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years von LILJA, Hans, ULMERT, David, BJÖRK, Thomas, BECKER, Charlotte, SERIO, Angel M, NILSSON, Jan-Ake, ABRAHAMSSON, Per-Anders, VICKERS, Andrew J, BERGLUND, Göran

Volltext

Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms von Chabot, Sophie, Dizeyi, Nishtman, Ramnemark, Lena, Lluel, Philippe, Abrahamsson, Per-Anders, Grabe, Magnus

Volltext

Neuroendocrine differentiation in prostatic carcinoma von Abrahamsson, Per-Anders

Volltext

Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines von Dizeyi, Nishtman, Ph.D, Hedlund, Petter, M.D., Ph.D, Bjartell, Anders, M.D., Ph.D, Tinzl, Martina, M.D, Austild-Taskén, Kristin, Ph.D, Abrahamsson, Per-Anders, M.D., Ph.D

Volltext

Is intermittent androgen‐deprivation therapy beneficial for patients with advanced prostate cancer? von Wolff, Johannes M., Abrahamsson, Per‐Anders, Irani, Jacques, Calais da Silva, Fernando

Volltext

The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia von Monsef, Nastaran, Soller, Maria, Isaksson, Margareth, Abrahamsson, Per Anders, Panagopoulos, Ioannis

Volltext

Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer von Sarwar, Martuza, Sandberg, Sabina, Abrahamsson, Per-Anders, M.D., Ph.D, Persson, Jenny L., Ph.D

Volltext

Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat von Aumüller, Gerhard, Doll, Andreas, Wennemuth, Gunther, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Wilhelm, Beate

Volltext

Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer von Tinzl, Martina, Chen, Binshen, Chen, Shao-Yong, Semenas, Julius, Abrahamsson, Per-Anders, Dizeyi, Nishtman

Volltext

Early Detection of Prostate Cancer: European Association of Urology Recommendation von Heidenreich, Axel, Abrahamsson, Per-Anders, Artibani, Walter, Catto, James, Montorsi, Francesco, Van Poppel, Hein, Wirth, Manfred, Mottet, Nicolas

Volltext

Preserving bone health in patients with hormone‐sensitive prostate cancer: the role of bisphosphonates von Saad, Fred, Abrahamsson, Per‐Anders, Miller, Kurt

Volltext

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019 von Gandaglia, Giorgio, Albers, Peter, Abrahamsson, Per-Anders, Briganti, Alberto, Catto, James W.F., Chapple, Christopher R., Montorsi, Francesco, Mottet, Nicolas, Roobol, Monique J., Sønksen, Jens, Wirth, Manfred, van Poppel, Hendrik

Volltext